Markey Cancer Center, University of Kentucky, Lexington, KY 40536, USA.
Hunan International Scientific and Technological Cooperation Base of Animal Models for Human Disease, School of Life Sciences, Central South University, Changsha 410078, China.
Int J Mol Sci. 2021 Oct 1;22(19):10665. doi: 10.3390/ijms221910665.
Breast cancer development is associated with macrophage infiltration and differentiation in the tumor microenvironment. Our previous study highlights the crucial function of reactive oxygen species (ROS) in enhancing macrophage infiltration during the disruption of mammary tissue polarity. However, the regulation of ROS and ROS-associated macrophage infiltration in breast cancer has not been fully determined. Previous studies identified retinoid orphan nuclear receptor alpha (RORα) as a potential tumor suppressor in human breast cancer. In the present study, we showed that retinoid orphan nuclear receptor alpha (RORα) significantly decreased ROS levels and inhibited ROS-mediated cytokine expression in breast cancer cells. RORα expression in mammary epithelial cells inhibited macrophage infiltration by repressing ROS generation in the co-culture assay. Using gene co-expression and chromatin immunoprecipitation (ChIP) analyses, we identified complex I subunits NDUFS6 and NDUFA11 as RORα targets that mediated its function in suppressing superoxide generation in mitochondria. Notably, the expression of RORα in 4T1 cells significantly inhibited cancer metastasis, reduced macrophage accumulation, and enhanced M1-like macrophage differentiation in tumor tissue. In addition, reduced RORα expression in breast cancer tissue was associated with an increased incidence of cancer metastasis. These results provide additional insights into cancer-associated inflammation, and identify RORα as a potential target to suppress ROS-induced mammary tumor progression.
乳腺癌的发展与肿瘤微环境中巨噬细胞的浸润和分化有关。我们之前的研究强调了活性氧(ROS)在破坏乳腺组织极性过程中增强巨噬细胞浸润的关键作用。然而,ROS 及其相关的巨噬细胞浸润在乳腺癌中的调控作用尚未完全确定。先前的研究确定了维甲酸孤儿核受体α(RORα)是人类乳腺癌的潜在肿瘤抑制因子。在本研究中,我们表明,维甲酸孤儿核受体α(RORα)可显著降低乳腺癌细胞中的 ROS 水平并抑制 ROS 介导的细胞因子表达。乳腺上皮细胞中 RORα 的表达通过抑制共培养实验中 ROS 的产生来抑制巨噬细胞的浸润。通过基因共表达和染色质免疫沉淀(ChIP)分析,我们确定了复合体 I 亚基 NDUFS6 和 NDUFA11 是 RORα 的靶标,介导其抑制线粒体中超氧生成的功能。值得注意的是,4T1 细胞中 RORα 的表达显著抑制了癌症转移,减少了肿瘤组织中巨噬细胞的积累,并增强了 M1 样巨噬细胞的分化。此外,乳腺癌组织中 RORα 的表达减少与癌症转移发生率的增加有关。这些结果为癌症相关炎症提供了更多的见解,并确定 RORα 是抑制 ROS 诱导的乳腺肿瘤进展的潜在靶点。